Skip to main content
Log in

Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

GK 13 (N-[1-(2-benzo (b) thiophenyl)-cyclohexyl] piperidine), GBR 12783 (1-[2-(diphenylmethoxy)ethyl] 4-(3-phenyl propenyl)-piperazine and dexamphetamine are three indirect catecholaminergic agonists, acting via different neurochemical mechanisms. We have compared their effects in rodents, in several behavioral tests. All three drugs increased locomotion. The stimulant locomotor effect of dexamphetamine was more easily antagonized by haloperidol than that of GBR 12783 and GK 13. Only dexamphetamine reversed reserpine-induced akinesia. This reversal was prevented by pretreatment with either GK 13 or GBR 12783. The three drugs reduced pentobarbital sleeping time in mice. They induced rotation ipsilateral to a unilateral 6-OHDA lesion of the nigrostriatal dopaminergic pathway. The stereotypies induced by GK 13 and GBR 12783 were essentially limited to sniffing. Haloperidol-induced catalepsy was apparently more easily antagonized by dexamphetamine than by GK 13 or GBR 12783. GK 13 and GBR 12783 had no significant effects on body temperature. The three drugs displayed an anti-immobility effect in the “despair test”. Dexamphetamine and GK 13 reversed the hypothermia induced by apomorphine (16 mg/kg), as well as reserpine-induced hypothermia and reserpine-induced ptosis. Dexamphetamine induced a dose-dependent anorectic effect, whereas GK 13 and GBR 12783 induced only a brief and partial anorexia. Similar observations were made on water intake. Pretreatment with either GBR 12783 or GK 13 did not affect the dexamphetamine-induced anorexia. Effects of the three drugs are discussed by reference to their known neurochemical properties on catecholaminergic transmission.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Askew BM (1963) A simple screening procedure for imipramine-like antidepressant agents. Life Sci 10:725–730

    Article  PubMed  Google Scholar 

  • Boissier JR, Simon P (1965) Action de la caféine sur la motilité spontanée de la Souris. Arch Int Pharmacodyn 158:212–221

    PubMed  Google Scholar 

  • Bonnet JJ, Costentin J (1986) GBR 12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo. Eur J Pharmacol 121:199–209

    Article  PubMed  Google Scholar 

  • Bonnet JJ, Lemasson MH, Costentin, J (1984) Simultaneous evaluation by a double labelling method of uptake inhibition and release of dopamine in synaptosomal preparation of rat striatum. Biochem Pharmacol 13:2129–2135

    Article  Google Scholar 

  • Bonnet JJ, Protais P, Chagraoui A, Costentin J (1986) 3H-GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system. Eur J Pharmacol 126:211–222

    Article  PubMed  Google Scholar 

  • Bourin M, Puech A, Chermat R, Doare L, Poncelet M, Simon P (1981) Profils psychopharmacologiques de nouveaux antidépresseurs comparés aux antidépresseurs classiques. L'Encéphale 7:235–242

    Google Scholar 

  • Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560–571

    PubMed  Google Scholar 

  • Carboni E, Imperato A, Perezzani L, Di Chiara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28 [3]:653–661

    Article  PubMed  Google Scholar 

  • Carlsson A (1970) Amphetamine and brain catecholamines. In: Costa E, Garattini S (eds) Amphetamines and related compounds. Raven Press, NY, pp 289–300

    Google Scholar 

  • Chagraoui A, Bonnet JJ, Protais P, Costentin J (1987) ln vivo binding of 3H-GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum. Neurosci Lett 78:175–179

    Article  PubMed  Google Scholar 

  • Chiuch CC, Moore KE (1974) Relative potencies ofd andl amphetamine in the release of dopamine from cat brain in vivo. Res Commun Chem Pathol Pharmacol 7:189–199

    PubMed  Google Scholar 

  • Ferris RM, Tang FL, Maxwell RA (1972) A comparison of the capacities of isomers of amphetamine, deoxypipradol and methylphenidate to inhibitit the uptake of tritiated catecholamines into rat cerebral cortex, hypothalamus, striatum and adrenergic nerves of rabbit aorta. J Pharmacol Exp Ther 181:407–417

    PubMed  Google Scholar 

  • Fuxe K, Ungerstedt U (1970) Histochemical, biochemical and functional studies on central monoamine neurons after acute and chronic amphetamine administration. In: Costa E, Garattini S (eds) Amphetamines and Related compounds. Raven Press, NY, pp 257–288

    Google Scholar 

  • Glowinski J (1970) Effects of amphetamine on various aspects of catecholamine metabolism in the central nervous system of the rat. In: Costa E, Garattini S (eds) Amphetamines and related compounds. Raven Press NY, pp 301–316

    Google Scholar 

  • Goldman CK, Marino L, Leibowitz SF (1985) Postsynaptic alpha 2-noradrenergic receptors mediate feeding induced by paraventricular injection of norepinephrine and clonidine. Eur J Pharmacol 115:11–19

    Article  PubMed  Google Scholar 

  • Groves PM, Rebec GV (1976) Biochemistry and behaviour: some central action of amphetamine and antipsychotic drugs. Annu Rev Psychol 27:91–127

    Article  PubMed  Google Scholar 

  • Harris JE, Baldessarini RJ (1973) Uptake of 3H-catecholamine by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues. Neuropharmacology 12:669–679

    Article  PubMed  Google Scholar 

  • Heikkila RE (1981) Differential effects of several dopamine uptake inhibitors and releasing agents on locomotor activity in normal and in reserpinized mice. Life Sci 28:1867–1873

    Article  PubMed  Google Scholar 

  • Heikkila RE, Orlanski H, Mytilineou C, Cohen G (1975) Amphetamine evaluation ofd andl isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex. J Pharmacol Exp Ther 194:47–56

    PubMed  Google Scholar 

  • Holmes JC, Rutledge CD (1976) Effects of thed andl isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of rat brain. Biochem Pharmacol 25:447–451

    Article  PubMed  Google Scholar 

  • Horn AS, Cuello AC, Miller RJ (1974) Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of the drugs on the uptake mechanisms and stimulation of adenylate cyclase activity. J Neurochem 22:265–270

    PubMed  Google Scholar 

  • Imperato A, Di Chiara G (1985) Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by transtriatal dialysis. J Neurosci 5:297–306

    PubMed  Google Scholar 

  • Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effects experiments. J Pharmacol Exp Ther 96:99–115

    Google Scholar 

  • Pellegrino LJ, Cushman AJ (1967) A stereotaxic atlas of the rat brain. Appleton-Century-Crofts, New York

    Google Scholar 

  • Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn 229:327–336

    PubMed  Google Scholar 

  • Puech AJ, Chermat A, Poncelet M, Doare L, Simon P (1981) Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics. Psychopharmacology 75:84–91

    Article  PubMed  Google Scholar 

  • Raiteri M, Bertollini A, Angelini F, Levi G (1975)d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol 34:189–195

    Article  PubMed  Google Scholar 

  • Raiteri M, Cerrito F, Cervoni AM, Levi B (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther 208:195–202

    PubMed  Google Scholar 

  • Rubin B, Mallone MH, Vaugh MH, Burke JC (1957) Bioassay of rauwolfia roots and alkaloids. J Pharmacol 120:125–136

    Google Scholar 

  • Scheel-Kruger J (1971) Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of catecholamines in the brain. Eur J Pharmacol 14:47–59

    Article  PubMed  Google Scholar 

  • Slimani M, Boucher D, Bonnet JJ, Kamenka JM, Costentin J (1988) Neurochemical and behavioral evidence for a central indirect dopaminergic agonist activity of GK 13, a phencyclidine derivative. In: Domino EF, Kamenka J-M (eds) Sigma and phencyclidine-like compounds as molecular probes in biology. NPP Books, Ann Arbor pp 511–520

    Google Scholar 

  • Sulser F, Watts J, Brodie BB (1962) On the mechanism of antidepressant action of imipramine-like drugs. Ann NY Acad Sci 98:279–288

    Google Scholar 

  • Svensson TH (1971) Functional and biochemical effects ofd andl amphetamine on central catecholamine neurons. Naunyn Schmiedeberg's Arch Pharmacol 45:287–294

    Google Scholar 

  • Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand [Suppl] 367:69–93

    Google Scholar 

  • Van der Zee P, Koger HS, Gotjes J, Hespe W (1980) Aryl 1,4-dialk (en) yl piperazines as selective and very potent inhibitors of dopamine uptake. Eur J Med Chem 15:363–370

    Google Scholar 

  • Vaugeois JM, Bonnet JJ, Costentin J (1990) Relationship between the effect of dexamphetamine on locomotion and on striatal 3H-GBR 12783 in vivo binding. Eur J Pharmacol (in press)

  • Vignon J, Pinet V, Cerruti C, Kamenka JM, Chicheportiche R (1988a) 3H-BTCP: a new phencyclidine analog selective for the dopamine uptake complex. Eur J Pharmacol 148:427–436

    Article  PubMed  Google Scholar 

  • Vignon J, Cerruti C, Chaudieu I, Pinet V, Chicheportiche M, Kamenka JM, Chicheportiche R (1988b) Interaction of molecules in the phencyclidine series with the dopamine uptake system: correlation with their binding properties to the phencyclidine receptor. Binding properties of3H-BTCP, a new PCP analog, to the dopamine uptake complex. In: Domino EF, Kamenka J-M (eds) Sigma and phencyclidine like compounds as molecular probes in biology. NPP Books, Ann Arbor, pp 199–208

    Google Scholar 

  • Westerink BHC, Damsma G, De Vries JB, Koning H (1987) Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat. Eur J Pharmacol 135:123–128

    Article  PubMed  Google Scholar 

  • Willner P (1983) Dopamine and depression: a review of recent evidence. Brain Res Rev 6:211–246

    Article  Google Scholar 

  • Zetterström T, Sharp T, Ungerstedt U (1984) Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 106:27–37

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duterte-Boucher, D., Kamenka, J.M. & Costentin, J. Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions. Psychopharmacology 101, 344–353 (1990). https://doi.org/10.1007/BF02244052

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244052

Key words

Navigation